cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.1157494.v1
title: Spectral characteristics of three styles of Croatian folk singing

description: Recordings from the LADO singers in three styles of Croatian folk song, and acoustic analyses, as published in Boersma & Kovačić (2006): Spectral characteristics of three styles of Croatian folk singing. Journal of the Acoustical Society of America 119: 1805-1816.
DOI: 10.6084/m9.figshare.1157559.v3
title: Hibbett Demo Data for RWTY

description: Demonstration data set for RWTY, an R package for visualizing MCMC chains in phylogenetics. The data used to create these chains is from Hibbett D., Pine E., Langer E., Langer G., & Donoghue M. 1997. Evolution of gilled mushrooms and puffballs inferred from ribosomal DNA sequences. Proceedings of the National Academy of Sciences of the United States of America, 94(22): 12002-12006. Data was downloaded from Dryad and analyzed using MrBayes version 3.2.1 with all program settings at default except for chain length, which was set to ten million generations.
DOI: 10.6084/m9.figshare.1157479
title: Data from: Is Great Britain heading for a Ponto-Caspian Invasional Meltdown?

description: Data used for manuscript JAPPL-2014-00321 accepted for publication in Journal of Applied Ecology. Species data is provided as csv files containing the longitude (X) and latitude (Y) of each location where the species has been found.
DOI: 10.6084/m9.figshare.1157494.v2
title: Spectral characteristics of three styles of Croatian folk singing

description: Recordings from the LADO singers in three styles of Croatian folk song, and acoustic analyses, as published in Boersma & Kovačić (2006): Spectral characteristics of three styles of Croatian folk singing. Journal of the Acoustical Society of America 119: 1805-1816.
DOI: 10.6084/m9.figshare.1157479.v2
title: Data from: Is Great Britain heading for a Ponto-Caspian Invasional Meltdown?

description: Data used for manuscript JAPPL-2014-00321 accepted for publication in Journal of Applied Ecology. Species data is provided as csv files containing the longitude (X) and latitude (Y) of each location where the species has been found.
DOI: 10.6084/m9.figshare.1157494.v4
title: Spectral characteristics of three styles of Croatian folk singing

description: Recordings from the LADO singers in three styles of Croatian folk song, and acoustic analyses, as published in Boersma & Kovačić (2006): Spectral characteristics of three styles of Croatian folk singing. Journal of the Acoustical Society of America 119: 1805-1816.
DOI: 10.6084/m9.figshare.1157494.v3
title: Spectral characteristics of three styles of Croatian folk singing

description: Recordings from the LADO singers in three styles of Croatian folk song, and acoustic analyses, as published in Boersma & Kovačić (2006): Spectral characteristics of three styles of Croatian folk singing. Journal of the Acoustical Society of America 119: 1805-1816.
DOI: 10.6084/m9.figshare.1157479.v1
title: Data archive, JAPPL-2014-00321

description: Data used for manuscript JAPPL-2014-00321 accepted for publication in Journal of Applied Ecology. Species data is provided as csv files containing the longitude (X) and latitude (Y) of each location where the species has been found.
DOI: 10.6084/m9.figshare.1157386
title: The pharmacology of statins in humans: a critical analysis

description: <strong>Table 1.</strong> Reanalysis of rosuvastatin serious adverse events. <strong>Table 2.</strong> Reanalysis of rosuvastatin non-serious adverse events. <strong>Statistical analysis: Chi-square</strong> <strong>_________________________________<br> </strong> <strong>Databases: Open (worldwide) - comments allowed</strong> <strong><br>1st URL:</strong> Google Spreadsheet - Analysis of the JUPITER trial (rosuvastatin) - NCT00239681 <strong>2nd URL:</strong> Google Spreadsheet - Statin registered studies at ClinicalTrials.gov and WHO ICTRP <strong>3rd URL:</strong> JUPITER complete database downloaded from ClinicalTrials.gov ____________________________ <strong>Comments about rosuvastatin JUPITER clinical trial</strong> <strong>1. Not all adverse drug reactions are included in Tables 1 and 2.</strong> <strong>2. Adverse events appear to be much higher than 18%. (1)</strong> <strong>3. Results available at ClinicalTrials.gov for the JUPITER study are not consistent with publications reporting the results of this trial.</strong> http://www.ncbi.nlm.nih.gov/pubmed/?term=NCT00239681 For example: Discordance between results reported in the number of patients diagnosed with diabetes mellitus. 1. ClinicalTrials.gov: Placebo=13; Rosuvastatin=14 | 2. Article (PMID: 22883507): Placebo=216; Rosuvastatin=270) <strong>4. Primary outcome was modified in the registry history available at ClinicalTrials.gov</strong> http://clinicaltrials.gov/archive/NCT00239681/2014_03_21/changes <strong>5. It is not clear why this study was terminated.</strong> March 13, 2008.<br><em>"Independent Data Monitoring Committee for JUPITER met and agreed that the studyshould continue as planned."</em> April 2, 2008.<br><em>"AstraZeneca announced it has decided to stop the CRESTOR JUPITER clinicalstudy early based on a recommendation from an Independent Data Monitoring Boardand the JUPITER Steering Committee, which met on March 29, 2008. The study willbe stopped early because there is unequivocal evidence of a reduction incardiovascular morbidity and mortality amongst patients who received CRESTOR when compared to placebo."</em> http://clinicaltrials.gov/archive/NCT00239681/2008_04_02/changes <strong>References</strong> 1. Should people at low risk of cardiovascular disease take a statin? BMJ 2014; 348:g3329
DOI: 10.6084/m9.figshare.1157387.v1
title: Soil associations and soil mapping units (including their clay and silt contents) in Thuringia, Saxony-Anhalt and Saxony (according to the revised FAO Legend (1990))

description: The Table shows the areas that the six soil associations and their assigned soil mapping units cover in the investigated regions of the three German Federal States of Thuringia, Saxony-Anhalt and Saxony. The table also includes information about the clay and silt contents of these soils, which is necessary for the assessment of the soil organic matter (Franko et al., 2011). This high degree of soil information is necessary because it allows a spatial differentiation in the landscape (not all soil associations are homogeneous) - which is important with regard to the designation of hot spots of high carbon demand. Large parts of the arable land in the study area are located on loess sediments. Soils in loess areas – where also chernosems can be found - cover 31.9% of the study area. All of these soils show high clay and silt contents, reaching from over 50 to 90%. The regional pattern of soil texture has been taken from the German soil map (BUEK1000; scale 1:1,000,000; Hartwich et al., 1998), which includes 72 soil mapping units in total. The mapping units are summarized to seven soil associations. This is a genetic-oriented approach, where the soils are grouped due to their different parent material and conditions relevant for soil formation (topography, climate, etc.) in the corresponding landscape.<br>49 of these 72 different soil mapping units can be found in our study area. Each soil unit has been assigned a characteristic soil profile (“Leitprofil”) where soil texture was derived by using the guidelines for soil mapping (Eckelmann et al., 2005). References: Eckelmann. W., Sponagel, H., Grottenthaler, W., Hartmann, K.-J., Hartwich, R., Janetzko, P., Joisten, H., Kühn, D., Sabel, K.-J., Traidl, R. (2005): Bodenkundliche Kartieranleitung. 5. verbesserte und erweiterte Auflage, Schweizerbart'sche Verlagsbuchhandlung, Stuttgart. Franko, U., Kolbe, H., Thiel, E., Ließ, E. (2011): Multi-site validation of a soil organic matter model for arable fields based on generally available input data. Geoderma 166, 119-134. Hartwich, R., Behrens, J., Eckelmann, W., Haase, G., Richter, A., Roeschmann, G., Schmidt, R. (1998): Bodenübersichtskarte der Bundesrepublik Deutschland. Bundesanstalt für Geologie und Rohstoffe, Hannover.
DOI: 10.6084/m9.figshare.1157374
title: HIST (Historical Information for Smell deTection) - Replication Package

description: Bad code smells are symptoms of poor design and implementation choices that may hinder code comprehensibility. While most of the detection techniques rely on structural information, many bad code smells are intrinsically characterized by how code elements change over time. In this paper, we propose HIST (Historical Information for Smell deTection), an approach exploiting change history information to detect instances of five different bad code smells, namely Divergent Change, Shotgun Surgery, Parallel Inheritance, Blob, and Feature Envy. We evaluate HIST in two empirical studies. The first, conducted on twenty open source projects, aimed at assessing the accuracy of HIST in detecting instances of the above mentioned bad code smells. In this study we compare HIST with state-of-the-art smell detectors based on source code analysis. The results indicate that HIST’s precision ranges between 72% and 86%, and its recall ranges between 58% and 100%. More importantly, the results indicate that HIST is able to identify bad code smells that cannot be identified through approaches solely based on code analysis. Then, we conducted a second study aimed at investigating to what extent the bad code smells detected by HIST (and by the competitive code analysis techniques) reflect developers’ perception of poor design and implementation choices. We involved twelve developers of four open source projects that recognized as design/implementation problems more than 75% of the bad code smell instances identified by HIST.
DOI: 10.6084/m9.figshare.1157386.v2
title: The pharmacology of statins in humans: a critical analysis

description: <strong>Table 1.</strong> Reanalysis of rosuvastatin serious adverse events. <strong>Table 2.</strong> Reanalysis of rosuvastatin non-serious adverse events. <strong>Statistical analysis: Chi-square</strong> <strong>_________________________________<br> </strong> <strong>Databases: Open (worldwide) - comments allowed</strong> <strong><br>1st URL:</strong> Google Spreadsheet - Analysis of the JUPITER trial (rosuvastatin) - NCT00239681 <strong>2nd URL:</strong> Google Spreadsheet - Statin registered studies at ClinicalTrials.gov and WHO ICTRP <strong>3rd URL:</strong> JUPITER complete database downloaded from ClinicalTrials.gov ____________________________ <strong>Comments about rosuvastatin JUPITER clinical trial</strong> <strong>1. Not all adverse drug reactions are included in Tables 1 and 2.</strong> <strong>2. Adverse events appear to be much higher than 18%. (1)</strong> <strong>3. Results available at ClinicalTrials.gov for the JUPITER study are not consistent with publications reporting the results of this trial.</strong> http://www.ncbi.nlm.nih.gov/pubmed/?term=NCT00239681 For example: Discordance between results reported in the number of patients diagnosed with diabetes mellitus. 1. ClinicalTrials.gov: Placebo=13; Rosuvastatin=14 | 2. Article (PMID: 22883507): Placebo=216; Rosuvastatin=270) <strong>4. Primary outcome was modified in the registry history available at ClinicalTrials.gov</strong> http://clinicaltrials.gov/archive/NCT00239681/2014_03_21/changes <strong>5. It is not clear why this study was terminated.</strong> March 13, 2008.<br><em>"Independent Data Monitoring Committee for JUPITER met and agreed that the studyshould continue as planned."</em> April 2, 2008.<br><em>"AstraZeneca announced it has decided to stop the CRESTOR JUPITER clinicalstudy early based on a recommendation from an Independent Data Monitoring Boardand the JUPITER Steering Committee, which met on March 29, 2008. The study willbe stopped early because there is unequivocal evidence of a reduction incardiovascular morbidity and mortality amongst patients who received CRESTOR when compared to placebo."</em> http://clinicaltrials.gov/archive/NCT00239681/2008_04_02/changes <strong>References</strong> 1. Should people at low risk of cardiovascular disease take a statin? BMJ 2014; 348:g3329
DOI: 10.6084/m9.figshare.1157386.v1
title: The pharmacology of statins in humans: a critical analysis

description: <strong>Table 1.</strong> Reanalysis of rosuvastatin serious adverse events. <strong>Table 2.</strong> Reanalysis of rosuvastatin non-serious adverse events. <strong>Statistical analysis: Chi-square</strong> <strong>_________________________________<br> </strong> <strong>Databases: Open (worldwide) - comments allowed</strong> <strong><br>1st URL:</strong> Google Spreadsheet - Analysis of the JUPITER trial (rosuvastatin) - NCT00239681 <strong>2nd URL:</strong> Google Spreadsheet - Statin registered studies at ClinicalTrials.gov and WHO ICTRP <strong>3rd URL:</strong> JUPITER complete database downloaded from ClinicalTrials.gov ____________________________ <strong>Comments about rosuvastatin JUPITER clinical trial</strong> <strong>1. Not all adverse drug reactions are included in Tables 1 and 2.</strong> <strong>2. Adverse events appear to be much higher than 18%. (1)</strong> <strong>3. Results available at ClinicalTrials.gov for the JUPITER study are not consistent with publications reporting the results of this trial.</strong> http://www.ncbi.nlm.nih.gov/pubmed/?term=NCT00239681 For example: Discordance between results reported in the number of patients diagnosed with diabetes mellitus. 1. ClinicalTrials.gov: Placebo=13; Rosuvastatin=14 | 2. Article (PMID: 22883507): Placebo=216; Rosuvastatin=270) <strong>4. Primary outcome was modified in the registry history available at ClinicalTrials.gov</strong> http://clinicaltrials.gov/archive/NCT00239681/2014_03_21/changes <strong>5. It is not clear why this study was terminated.</strong> March 13, 2008.<br><em>"Independent Data Monitoring Committee for JUPITER met and agreed that the studyshould continue as planned."</em> April 2, 2008.<br><em>"AstraZeneca announced it has decided to stop the CRESTOR JUPITER clinicalstudy early based on a recommendation from an Independent Data Monitoring Boardand the JUPITER Steering Committee, which met on March 29, 2008. The study willbe stopped early because there is unequivocal evidence of a reduction incardiovascular morbidity and mortality amongst patients who received CRESTOR when compared to placebo."</em> http://clinicaltrials.gov/archive/NCT00239681/2008_04_02/changes <strong>References</strong> 1. Should people at low risk of cardiovascular disease take a statin? BMJ 2014; 348:g3329
DOI: 10.6084/m9.figshare.1157374.v1
title: HIST (Historical Information for Smell deTection) - Replication Package

description: Bad code smells are symptoms of poor design and implementation choices that may hinder code comprehensibility. While most of the detection techniques rely on structural information, many bad code smells are intrinsically characterized by how code elements change over time. In this paper, we propose HIST (Historical Information for Smell deTection), an approach exploiting change history information to detect instances of five different bad code smells, namely Divergent Change, Shotgun Surgery, Parallel Inheritance, Blob, and Feature Envy. We evaluate HIST in two empirical studies. The first, conducted on twenty open source projects, aimed at assessing the accuracy of HIST in detecting instances of the above mentioned bad code smells. In this study we compare HIST with state-of-the-art smell detectors based on source code analysis. The results indicate that HIST’s precision ranges between 72% and 86%, and its recall ranges between 58% and 100%. More importantly, the results indicate that HIST is able to identify bad code smells that cannot be identified through approaches solely based on code analysis. Then, we conducted a second study aimed at investigating to what extent the bad code smells detected by HIST (and by the competitive code analysis techniques) reflect developers’ perception of poor design and implementation choices. We involved twelve developers of four open source projects that recognized as design/implementation problems more than 75% of the bad code smell instances identified by HIST.
DOI: 10.6084/m9.figshare.1157161
title: Statistics of Natural Binaural Sounds - Supplementary Material

description: Wiktor Mlynarski, Juergen Jost (2014) Statistics of Natural Binaural Sounds, PLOS One 9(10): e108968. doi:10.1371/journal.pone.0108968 Each file is a 12 minute binaural recording of a natural auditory scene. Data were used to analyze statistics of stimuli processed by the auditory system in the natural environment. 1. Nocturnal nature - the recording subject sat in a randomly selected position in the garden during summer evening. During the recording the subject was keeping his head still, looking ahead, with his chin parallel to the ground. The dominating background sound were grasshopper calls. Other acoustic events included sounds of a distant storm and a few cars passing by on a near-by road. The spatial configuration of this scene did not change much in time - the scene was almost static. 2. Forest walk - this recording was performed by a subject freely moving in the wooded area. The second speaker was present, engaged in a free conversation with the recording subject. In addition to speech, this scene included environmental sounds such as flowing water, cracks of broken sticks,leave crunching, wind etc. Binaural signal was affected not only by the spatial scene configuration, but also by head and body motion patterns of the recording subject. 3. City center - the recording subject sat in a touristic area of an old part of town, fixating the head as in the previous case. During the recording many moving and static human speakers were present. Contrasted with the previous example, the spatial configuration of the scene varied continuously. Two of the analyzed auditory scenes (nocturnal nature and city center) were recorded by a non-<br>moving subject, therefore sound statistics were unaffected by listener’s motion patterns and self generated sounds. In the third scene (forest walk) the subject was moving freely and was speaking sparsely. Recordings were performed using the Soundman OKM-II binaural microphones which were placed in the left and the right ear channels of the recording subject. Soudmann DR2 recorder was used to simultaneously record sound in both channels in an uncompressed wave format at 44100 Hz sampling rate. The head circumference of the recording subject was equal to 60 cm.
DOI: 10.6084/m9.figshare.1157154
title: Vortex Ventilation in the Laboratory Environment

description: Assured containment at low airflow has long eluded the users of ventilated enclosures including chemical fume hoods used throughout industry. It is proposed that containment will be enhanced in a hood that has a particular interior shape that causes a natural vortex to occur. The sustained vortex improves the containment of contaminants within the enclosure at low airflow. This hypothesis was tested using the ASHRAE 110 tracer gas test. A known volume of tracer gas was emitted in the hood. A MIRAN SapphIRe infrared spectrometer was used to measure the concentration of tracer gas that escapes the enclosure. The design of the experiment included a written operating procedure, data collection plan, and statistical analysis of the data. A chemical fume hood of traditional design was tested. The hood interior was then reconstructed to enhance the development of a vortex inside the enclosure. The hood was retested using the same method to compare the performance of the traditional interior shape with the enhanced vortex shape. In every aspect, the vortex hood showed significant improvement over the traditional hood design. Use of the Hood Index characterizing the dilution of gas in an air stream as a logarithmic function indicates a causal relationship between containment and volumetric airflow through an enclosure. Use of the vortex effect for ventilated enclosures can provide better protection for the user and lower operating cost for the owner.[Supplementary materials are available for this article. Go to the publisher's online edition of <i>Journal of Occupational and Environmental Hygiene</i> for the following free supplemental resource: a data collection spreadsheet, data analysis, and data collection procedure.]
DOI: 10.6084/m9.figshare.1157154.v1
title: Vortex Ventilation in the Laboratory Environment

description: Assured containment at low airflow has long eluded the users of ventilated enclosures including chemical fume hoods used throughout industry. It is proposed that containment will be enhanced in a hood that has a particular interior shape that causes a natural vortex to occur. The sustained vortex improves the containment of contaminants within the enclosure at low airflow. This hypothesis was tested using the ASHRAE 110 tracer gas test. A known volume of tracer gas was emitted in the hood. A MIRAN SapphIRe infrared spectrometer was used to measure the concentration of tracer gas that escapes the enclosure. The design of the experiment included a written operating procedure, data collection plan, and statistical analysis of the data. A chemical fume hood of traditional design was tested. The hood interior was then reconstructed to enhance the development of a vortex inside the enclosure. The hood was retested using the same method to compare the performance of the traditional interior shape with the enhanced vortex shape. In every aspect, the vortex hood showed significant improvement over the traditional hood design. Use of the Hood Index characterizing the dilution of gas in an air stream as a logarithmic function indicates a causal relationship between containment and volumetric airflow through an enclosure. Use of the vortex effect for ventilated enclosures can provide better protection for the user and lower operating cost for the owner.[Supplementary materials are available for this article. Go to the publisher's online edition of <i>Journal of Occupational and Environmental Hygiene</i> for the following free supplemental resource: a data collection spreadsheet, data analysis, and data collection procedure.]
DOI: 10.6084/m9.figshare.1157154.v3
title: Vortex Ventilation in the Laboratory Environment

description: Assured containment at low airflow has long eluded the users of ventilated enclosures including chemical fume hoods used throughout industry. It is proposed that containment will be enhanced in a hood that has a particular interior shape that causes a natural vortex to occur. The sustained vortex improves the containment of contaminants within the enclosure at low airflow. This hypothesis was tested using the ASHRAE 110 tracer gas test. A known volume of tracer gas was emitted in the hood. A MIRAN SapphIRe infrared spectrometer was used to measure the concentration of tracer gas that escapes the enclosure. The design of the experiment included a written operating procedure, data collection plan, and statistical analysis of the data. A chemical fume hood of traditional design was tested. The hood interior was then reconstructed to enhance the development of a vortex inside the enclosure. The hood was retested using the same method to compare the performance of the traditional interior shape with the enhanced vortex shape. In every aspect, the vortex hood showed significant improvement over the traditional hood design. Use of the Hood Index characterizing the dilution of gas in an air stream as a logarithmic function indicates a causal relationship between containment and volumetric airflow through an enclosure. Use of the vortex effect for ventilated enclosures can provide better protection for the user and lower operating cost for the owner.[Supplementary materials are available for this article. Go to the publisher's online edition of <i>Journal of Occupational and Environmental Hygiene</i> for the following free supplemental resource: a data collection spreadsheet, data analysis, and data collection procedure.]